Financial insights of NGNE

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2024-09-30	2024-06-30
Revenue under licensing agreements	0	0	-	925
Research and development expenses	17,241	19,366	16,285	15,744
General and administrative expenses	6,557	6,715	5,895	5,315
Total operating expenses	23,798	26,081	22,180	21,059
Loss from operations	-23,798	-26,081	-22,180	-20,134
Interest income	2,739	2,928	1,842	2,035
Interest expense	1	1	3	4
Other income	149	1,212	143	144
Other expense	42	74	19	533
Net loss	-20,953	-22,016	-20,217	-18,492

Net loss per share, basic (in dollars per share)	-0.99	-1.05	-1.19	-1.09
Net loss per share, diluted (in dollars per share)	-0.99	-1.05	-1.19	-1.09
Weighted-average shares of common stock outstanding, basic (in shares)	21,168,431	21,055,378	16,953,443	16,941,524
Weighted-average shares of common stock outstanding, diluted (in shares)	21,168,431	21,055,378	16,953,443	16,941,524